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Background
Chloroquine (CQ) and artesunate (AS) are widely used as
blood schizontocides in P. vivax treatment. Recent clini-
cal observations show late stage parasites are cleared
more rapidly than expected post treatment. As the high
deformability of P. vivax facilitates its escaping from the
splenic clearance, we hypothesize that CQ and AS
directly affect the P. vivax infected red blood cells
(iRBCs) rigidity. As a consequence, parasites are rapidly
cleared from the blood circulation.
Materials and methods
P. vivax isolates from Thailand were pulse incubated with
AS, CQ and a spiroindolone (NITD609). Morphological
changes and rosetting frequency were assessed by sub vital
staining. The micropipette aspiration technique was the
used to quantify the cell membrane shear modulus.
Microfluidics were used to study the in vitro iRBCs
behaviour after drug treatment.
Results
While CQ and AS did not directly affect iRBC shear mod-
ulus, it significantly enhanced rosetting frequency and
consequently the rigidity of rosetted iRBCs (the attach-
ment of a single red cell results in a significant increase in
shear modulus of the iRBC). NITD609 directly affected
the iRBC rigidity. A microfluidic model of the spleen
shows that P. vivax iRBCs with a higher rigidity are
removed from flow. This study also show that normocytes
that rosette with P. vivax iRBCs; form strong attachments
(~500pN) that withstand a range of physiological shear
stresses.
Conclusions
In addition to providing new and important baseline bio-
mechanical data on P. vivax rosettes; this ex vivo study also
provides a possible explanation for the clinically observed
disappearance of P. vivax parasites soon after treatment.
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